Indapamid Stada (Indapamide)

Indapamide blocks the Na⁺/Cl⁻ cotransporter in the distal convoluted tubule of the kidney, decreasing sodium and chloride reabsorption. This promotes diuresis, lowers plasma volume, and reduces peripheral vascular resistance, leading to lower blood pressure.

The appropriate dose of Indapamid Stada is determined by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and renal function. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Safety data for indapamide in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Indapamide belongs to the thiazide‑like class, offering potent antihypertensive and diuretic effects with a lower incidence of metabolic side effects compared with some thiazide diuretics. It is often preferred when a longer‑acting agent with favorable vascular effects is desired.

Indapamid Stada should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children.

Indapamid Stada is taken orally, usually with a glass of water. It can be administered with or without food, but consistency with regard to meals helps maintain stable absorption. Follow the prescriber’s directions for timing and frequency.

Serious risks include severe dehydration, marked electrolyte disturbances (especially low potassium or sodium), allergic reactions such as rash or angioedema, and rare blood disorders. Patients should be monitored for signs of these conditions and seek medical attention promptly if they occur.

Indapamid Stada is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide-derived drugs, severe renal impairment, and in individuals with anuria. Caution is also advised for patients with severe hypotension or electrolyte imbalances.